{"id":"W4311500730","doi":"10.1016/j.pharmthera.2022.108330","title":"Sodium-glucose co-transporter 2 inhibitors in patients with chronic kidney disease","year":2022,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"Fonds de Recherche du Québec - Santé","keywords":"Empagliflozin; Canagliflozin; Medicine; Dapagliflozin; Kidney disease; Diabetes mellitus; Population; Heart failure; Disease; Internal medicine; Pharmacology; Type 2 diabetes; Intensive care medicine; Endocrinology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004235754,0.0008688478,0.001906586,0.001672451,0.000163103,0.0007222198,0.0005090075,0.0007757572,0.005313266],"category_scores_gemma":[0.0007613635,0.0002492344,0.0007510608,0.001682633,0.0002047088,0.0007171469,0.0005039272,0.001624567,0.001114333],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003851391,"about_ca_system_score_gemma":0.0008470495,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001150994,"about_ca_topic_score_gemma":0.00453844,"domain_scores_codex":[0.9998649,0.00003105831,0.00002847588,0.00002109997,0.00003939385,0.00001491607],"domain_scores_gemma":[0.9996994,0.0001479699,0.00007954904,0.00000501483,0.00004524699,0.00002281674],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002941424,0.0001014281,0.0002086723,0.0312038,0.000436823,0.0001015642,0.00002789886,0.0002070634,0.0006324815,0.001072794,0.02796115,0.9377522],"study_design_scores_gemma":[0.0006799566,0.0005418259,0.004113567,0.0276474,0.003144246,0.001390245,0.00007669409,0.0004006636,0.0005589952,0.002368898,0.9590229,0.00005454454],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001073679,0.9987749,0.00006227919,0.0002301854,0.0001472258,0.000004574021,0.0000210834,0.000005401957,0.0006469379],"genre_scores_gemma":[0.0008868713,0.9980074,0.000128554,0.0003676012,0.0001881948,0.000007400426,0.00002518993,9.176781e-7,0.0003879036],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005313266,"threshold_uncertainty_score":0.0177747,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03482235961102632,"score_gpt":0.3352237035568663,"score_spread":0.3004013439458399,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}